Because retatrutide is only available through clinical trials, your first point of contact for any side effects including sleep disturbances should be your trial investigator or the clinical team overseeing your participation
Its a catastrophic and entirely avoidable problem
Currently, yes semaglutide has proven cardiovascular benefit from the SELECT trial (2023), which demonstrated significant reduction in major adverse cardiovascular events (heart attack, stroke, cardiovascular death) in patients with obesity and established heart disease
In the UK it remains available only as a research compound for laboratory use not for human consumption until a regulator says otherwise
These medications offer undeniable benefits for many, but they come with complex trade-offsphysical, emotional, and even psychologicalthat deserve thoughtful consideration
Islet specific transcription factor Pdx1 has the function of maintaining islets cell identity, inhibiting the transformation of cell to cell and promoting the secretion of insulin by cell (Ebrahim et al., 2022)
